Antimicrobial Agents Practice Questions

Q: Which of the following antitubercular drugs penetrates caseous necrosis?

Rifampicin. **Explanation:** The hallmark of tuberculosis is the formation of granulomas with a central area of **caseous necrosis**. This cheese-like, necrotic tissue is avascular and acidic, making it difficult for many drugs to penetrate and maintain therapeutic concentrations. **Why Rifampicin is correct:** Rifampicin is a highly lipid-soluble drug. This high lipid solubility allows it to penetrate effectively into various tissues, including the thick, lipid-rich walls of the tubercle bacilli and the **caseous material** within granulomas. It is uniquely effective against "persisters"—organisms that are metabolically inactive but can cause relapse—because it can reach them within these necrotic zones. **Why the other options are incorrect:** * **Isoniazid (INH):** While INH has excellent penetration into cerebrospinal fluid (CSF) and intracellular compartments, its penetration into solid caseous material is significantly lower than that of Rifampicin. * **Pyrazinamide:** This drug is highly effective in the **acidic environment** found within macrophages and at the edges of necrotic areas, but it does not penetrate the bulk of caseous necrosis as effectively as Rifampicin. * **Streptomycin:** As an aminoglycoside, it is highly polar and water-soluble. It has very poor penetration into cells and necrotic tissues and is completely inactive in acidic environments (like caseum). **High-Yield Clinical Pearls for NEET-PG:** * **Rifampicin:** Potent inducer of Cytochrome P450 enzymes; causes orange-discoloration of body fluids (urine, sweat, tears). * **Sterilizing effect:** Rifampicin and Pyrazinamide are the two drugs with the highest "sterilizing activity," crucial for shortening the duration of therapy. * **Site of action:** Pyrazinamide acts on intracellular bacilli (acidic pH); Streptomycin acts on extracellular bacilli (alkaline pH).

Q: All of the following drugs are administered orally except?

Gentamicin. ### Explanation The correct answer is **Gentamicin**. **1. Why Gentamicin is the correct answer:** Gentamicin belongs to the **Aminoglycoside** class of antibiotics. These drugs are highly polar, polycationic molecules. Due to their high polarity and lack of lipid solubility, they are **not absorbed from the gastrointestinal tract** (except in cases of severe mucosal damage). Therefore, they must be administered parenterally (IM or IV) for systemic infections. Oral administration of aminoglycosides (like Neomycin) is only used for local effects within the gut, such as bowel preparation before surgery or treating hepatic coma. **2. Why the other options are incorrect:** * **Ciprofloxacin (Fluoroquinolone):** This drug has excellent oral bioavailability (approx. 70-80%). It is commonly used orally for urinary tract infections and respiratory infections. * **Cotrimoxazole (Sulfamethoxazole + Trimethoprim):** This fixed-dose combination is well-absorbed from the GI tract and is frequently prescribed as an oral tablet for conditions like PCP pneumonia prophylaxis and UTIs. * **Amoxicillin (Penicillin):** Unlike Penicillin G, Amoxicillin is acid-stable and specifically designed for oral use, showing nearly complete absorption regardless of food intake. **3. High-Yield Clinical Pearls for NEET-PG:** * **Aminoglycoside Rule:** "All aminoglycosides are poorly absorbed orally." (Gentamicin, Streptomycin, Amikacin, Tobramycin). * **Exception:** **Neomycin** is given orally, but not for systemic action; it is used to "sterilize" the gut. * **Mechanism of Action:** Aminoglycosides inhibit protein synthesis by binding to the **30S ribosomal subunit** and are bactericidal. * **Adverse Effects:** Remember the "Three N's": **N**ephrotoxicity (reversible), **N**eurotoxicity (Ototoxicity - often irreversible), and **N**euromuscular blockade.

Q: What is the drug of choice for Pneumocystis jirovecii pneumonia?

Cotrimoxazole. **Explanation:** **Cotrimoxazole** (a fixed-dose combination of Sulfamethoxazole and Trimethoprim) is the **drug of choice** for both the treatment and prophylaxis of *Pneumocystis jirovecii* pneumonia (PCP), particularly in immunocompromised patients such as those with HIV/AIDS. **Why Cotrimoxazole is correct:** The mechanism involves a sequential blockade of folate synthesis. Sulfamethoxazole inhibits dihydropteroate synthase, while Trimethoprim inhibits dihydrofolate reductase. This synergy is highly effective against *P. jirovecii*, which, despite being a fungus, lacks ergosterol and does not respond to standard antifungals, but is susceptible to folate antagonists. **Why other options are incorrect:** * **Doxycycline & Tetracycline:** These are bacteriostatic protein synthesis inhibitors (30S subunit). While effective against atypical bacteria and some protozoa (like malaria), they have no clinical activity against *P. jirovecii*. * **Dapsone:** While Dapsone is used as a **second-line** alternative for PCP prophylaxis in patients who cannot tolerate Cotrimoxazole, it is less effective and is not the primary drug of choice. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylaxis Criteria:** In HIV-positive patients, PCP prophylaxis with Cotrimoxazole is initiated when the **CD4 count falls below 200 cells/μL**. * **Alternative for Treatment:** If a patient is allergic to sulfa drugs or fails Cotrimoxazole, the combination of **Primaquine + Clindamycin** or **Pentamidine** (IV/Inhaled) is used. * **Adjuvant Therapy:** In severe cases (PaO2 <70 mmHg), **Corticosteroids** are added to reduce the inflammation caused by dying organisms, which can otherwise worsen respiratory failure.

Q: The condition shown in the image is due to excessive/rapid usage of?

Vancomycin. ***Vancomycin*** - **Red Man Syndrome** occurs due to **rapid vancomycin infusion**, causing **non-IgE-mediated mast cell degranulation** and histamine release. - Presents with characteristic **diffuse erythematous flushing** of face, neck, and upper torso, often accompanied by **hypotension** and **pruritus**. *Piperacillin* - A **beta-lactam antibiotic** that does not cause **Red Man Syndrome** or histamine-mediated reactions. - Side effects include **allergic reactions** and **Clostridium difficile-associated diarrhea**, but not the characteristic flushing pattern. *Metronidazole* - An **antimicrobial agent** used against anaerobic bacteria and protozoa, not associated with **Red Man Syndrome**. - Common side effects include **metallic taste**, **nausea**, and **disulfiram-like reaction** with alcohol, not histamine release. *Teicoplanin* - A **glycopeptide antibiotic** similar to vancomycin but has **lower incidence** of **Red Man Syndrome**. - Generally **better tolerated** than vancomycin with less frequent histamine-mediated reactions due to different infusion characteristics.

Q: Which among the following fluoroquinolones has the longest half-life?

Moxifloxacin. The correct answer is **Moxifloxacin**. Fluoroquinolones are classified based on their pharmacokinetic profiles and spectrum of activity. The half-life ($t_{1/2}$) determines the dosing frequency of these drugs. **Moxifloxacin** has a significantly longer half-life (approximately **12–15 hours**) compared to earlier generations, allowing for convenient **once-daily dosing** [1]. It is primarily metabolized by the liver (glucuronide and sulfate conjugation) and excreted via bile, making it a preferred choice in patients with renal impairment. **Analysis of Options:** * **Levofloxacin (Option A):** Has a half-life of about **6–8 hours** [1]. While it can be dosed once daily due to its high potency and post-antibiotic effect, its $t_{1/2}$ is shorter than Moxifloxacin. * **Lomefloxacin (Option B):** Has a half-life of approximately **8 hours**. It is a second-generation agent known for causing significant phototoxicity. * **Ciprofloxacin (Option C):** Has a relatively short half-life of **3–5 hours** [1], typically requiring twice-daily (BD) dosing for most systemic infections. **High-Yield Clinical Pearls for NEET-PG:** * **Respiratory Quinolones:** Moxifloxacin, Levofloxacin, and Gemifloxacin are termed "Respiratory Quinolones" due to enhanced activity against *S. pneumoniae*. * **Excretion:** Moxifloxacin is the only fluoroquinolone **not used for UTIs** because it does not reach adequate concentrations in the urine (due to hepatic excretion). * **Side Effects:** All fluoroquinolones carry a risk of **tendon rupture** (Achilles tendon) and **QT interval prolongation**. Moxifloxacin has the highest risk of QT prolongation among the common quinolones. * **Longest Half-life overall:** While not in these options, **Fleroxacin** (~10 hours) and **Sparfloxacin** (~18–20 hours) also have long half-lives [1], but Moxifloxacin remains the most clinically relevant long-acting agent in modern practice.

Q: What is the recommended daily dose of amphotericin B for a patient with suspected severe fungal infection?

120-160 mEq over 24 hours. **Explanation:** The correct answer is **D (120-160 mEq over 24 hours)**. However, it is critical to clarify a common point of confusion in pharmacology exams: this dosage refers to **Potassium (K+) supplementation**, not the dose of Amphotericin B itself. **1. Why Option D is Correct:** Amphotericin B is notorious for causing **nephrotoxicity**, specifically affecting the distal renal tubules. This leads to **Type 1 Renal Tubular Acidosis (RTA)**, characterized by significant wasting of potassium and magnesium. In severe fungal infections requiring high-dose Amphotericin B, the resulting hypokalemia can be life-threatening. To counteract this "leaky tubule" effect, aggressive electrolyte replacement is required, often totaling **120-160 mEq of Potassium per day** to maintain homeostasis. **2. Why Other Options are Incorrect:** * **Options A, B, and C (40, 60, 80 mEq):** These represent standard daily potassium requirements for stable patients or those with mild depletion. They are insufficient to compensate for the massive renal potassium loss induced by the "amphoterrible" effect on the tubular membranes. **3. NEET-PG High-Yield Pearls:** * **Mechanism of Toxicity:** Amphotericin B creates artificial pores in the renal tubular epithelial membranes (similar to its action on fungal ergosterol), leading to ion leakage. * **Pre-loading:** To minimize nephrotoxicity, clinicians "salt-load" the patient with **500ml–1L of Normal Saline** before infusion. * **Liposomal Amphotericin B:** This formulation is preferred as it is significantly less nephrotoxic than the conventional Deoxycholate form. * **Monitoring:** Always monitor Serum K+, Mg2+, and Creatinine levels daily. **Note for Students:** If the question asks for the dose of **Amphotericin B Deoxycholate**, it is **0.5–1.0 mg/kg/day**. If it asks for the **Potassium supplement** required during therapy, the answer is **120-160 mEq/day**.

Q: Which of the following is recommended as a dual-active drug targeting both HBV and HIV?

Tenofovir. **Explanation:** The management of HIV/HBV co-infection requires drugs that exhibit potent activity against both viruses to prevent the development of resistance and simplify dosing regimens. **Why Tenofovir is Correct:** Tenofovir (available as Tenofovir Disoproxil Fumarate - TDF or Tenofovir Alafenamide - TAF) is a **Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI)**. It inhibits the reverse transcriptase enzyme in HIV and the DNA polymerase in HBV. It is considered a first-line agent for both infections due to its high genetic barrier to resistance and superior efficacy. In co-infected patients, Tenofovir is almost always included as part of the ART (Antiretroviral Therapy) backbone. **Analysis of Incorrect Options:** * **Entecavir (A):** While it is a potent anti-HBV drug, it has weak activity against HIV. Using it in a co-infected patient not on ART can lead to the **M184V mutation** in HIV, causing cross-resistance to Lamivudine. * **Adefovir (B):** It is used for HBV but is ineffective against HIV at the doses used for hepatitis. Higher doses required for HIV are highly nephrotoxic. * **Zidovudine (D):** This is an NRTI used for HIV (especially in pregnancy/PMTCT), but it has **no activity** against the HBV virus. **High-Yield Clinical Pearls for NEET-PG:** * **Dual-active drugs:** Tenofovir, Lamivudine (3TC), and Emtricitabine (FTC) are the three main drugs active against both HIV and HBV. * **The "Flare" Phenomenon:** If a dual-active drug like Tenofovir is discontinued in a co-infected patient, it can lead to a life-threatening "rebound" or flare of Hepatitis B. * **Preferred Regimen:** The WHO and NACO recommend a TDF + 3TC (or FTC) + Dolutegravir (DTG) regimen for most HIV/HBV co-infected patients.

Q: Which of the following anti-influenza drugs can cause Livedo reticularis?

Amantadine. **Explanation:** **Amantadine** is the correct answer. It is an M2 ion channel blocker primarily used against Influenza A (though now largely obsolete due to widespread resistance) and in the management of Parkinson’s disease. **Mechanism of Livedo Reticularis:** Amantadine causes **Livedo reticularis**—a purplish, net-like pattern of vascular discoloration on the skin—by promoting the release of catecholamines from peripheral nerve terminals. This leads to localized vasoconstriction of dermal vessels and subsequent venous stasis. This side effect is usually benign and reversible upon discontinuation of the drug. **Analysis of Incorrect Options:** * **Rimantadine (Option B):** A derivative of amantadine with a similar mechanism (M2 blocker). While it shares some side effects, it has a much lower incidence of CNS effects and is significantly less associated with Livedo reticularis compared to amantadine. * **Zanamivir and Laninamivir (Options A & D):** These are **Neuraminidase Inhibitors**. Their side effect profiles are different; Zanamivir is administered via inhalation and can cause bronchospasm, while Laninamivir is a long-acting neuraminidase inhibitor. Neither is associated with Livedo reticularis. **High-Yield Clinical Pearls for NEET-PG:** * **Amantadine Triple Action:** It acts as an antiviral, an antiparkinsonian agent (increases dopamine release), and an NMDA antagonist. * **Other Side Effects:** It can cause ankle edema and "Amantadine-induced psychosis" (hallucinations). * **Livedo Reticularis Differential:** Apart from Amantadine, it is also seen in systemic conditions like SLE, Polyarteritis Nodosa (PAN), and Antiphospholipid Syndrome (APS). * **Neuraminidase Inhibitors:** Oseltamivir (oral), Zanamivir (inhaled), and Peramivir (IV) are active against both Influenza A and B.

Q: A healthcare worker has a needle-stick injury exposure to HIV. Which of the following drug regimens is indicated for post-exposure prophylaxis?

Zidovudine + Lamivudine + Indinavir for 4 weeks. ### Explanation **Correct Option: A (Zidovudine + Lamivudine + Indinavir for 4 weeks)** Post-exposure prophylaxis (PEP) for HIV is categorized based on the severity of exposure. For **high-risk exposures** (e.g., deep needle-stick injuries with a high viral load source), an expanded regimen consisting of **three drugs** is indicated. The combination of two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) like **Zidovudine and Lamivudine** plus a Protease Inhibitor (PI) like **Indinavir** (or Lopinavir/Ritonavir) is the classic recommendation to ensure maximum viral suppression. The duration of treatment is strictly **4 weeks (28 days)**. **Analysis of Incorrect Options:** * **Option B:** Nevirapine (an NNRTI) is contraindicated in PEP because it carries a high risk of severe hepatotoxicity and Stevens-Johnson Syndrome (SJS) in HIV-negative individuals. * **Option C:** Zidovudine and Stavudine should never be used together. Both are thymidine analogs that compete for the same phosphorylation pathway, leading to **pharmacological antagonism**. * **Option D:** This two-drug regimen (Basic Regimen) was previously used for low-risk exposures. However, current guidelines (WHO/NACO) now favor a three-drug regimen for all significant exposures to simplify protocols and increase efficacy. **High-Yield Clinical Pearls for NEET-PG:** * **Timing:** PEP should be started as soon as possible, ideally within **2 hours**, and definitely within **72 hours** of exposure. * **Current NACO/WHO Preferred Regimen:** Tenofovir (TDF) + Lamivudine (3TC) + Dolutegravir (DTG). * **Monitoring:** Baseline HIV testing should be done, followed by repeat testing at 6 weeks, 3 months, and 6 months. * **Zidovudine Side Effects:** Most common is anemia (bone marrow suppression) and GI intolerance.

Q: Metronidazole is indicated in the treatment of which one of the following conditions?

Helicobacter pylori infection. **Explanation:** **Metronidazole** is a nitroimidazole derivative that acts by forming reactive cytotoxic intermediates that cause DNA strand breakage. It is primarily effective against **obligate anaerobes** and certain **protozoa**. **1. Why Option D is Correct:** *Helicobacter pylori* is a microaerophilic, Gram-negative bacterium. Metronidazole is a core component of several multidrug regimens (such as the **Bismuth-based Quadruple Therapy** or the **Clarithromycin-based Triple Therapy**) used to eradicate *H. pylori*. It is particularly useful in patients allergic to penicillin or in regions where resistance patterns allow its use. **2. Why Other Options are Incorrect:** * **A & B (Traveller's Diarrhea / E. coli):** These are most commonly caused by Enterotoxigenic *E. coli* (ETEC). The drugs of choice are **Fluoroquinolones** (like Ciprofloxacin) or **Rifaximin**. Metronidazole has no activity against aerobic Gram-negative rods like *E. coli*. * **C (Cryptosporidium):** This protozoan causes self-limiting diarrhea in immunocompetent hosts but severe diarrhea in AIDS patients. The drug of choice is **Nitazoxanide**. Metronidazole is ineffective against *Cryptosporidium*. **3. High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Metronidazole is the DOC for **Pseudomembranous colitis** (mild-to-moderate *C. difficile*), **Amoebiasis**, **Giardiasis**, **Trichomoniasis**, and **Bacterial Vaginosis**. * **Disulfiram-like Reaction:** Patients must avoid alcohol while on Metronidazole due to the inhibition of aldehyde dehydrogenase. * **Side Effects:** Metallic taste, nausea, and peripheral neuropathy (with long-term use). * **Mechanism:** It requires reductive activation of the nitro group by the enzyme **pyruvate:ferredoxin oxidoreductase (PFOR)**, found only in anaerobes.

Question 1

Which of the following antitubercular drugs penetrates caseous necrosis?

Accepted Answer

Rifampicin

Answer

Isoniazid (INH)

Answer

Pyrazinamide

Answer

Streptomycin

Question 2

All of the following drugs are administered orally except?

Accepted Answer

Gentamicin

Answer

Ciprofloxacin

Answer

Cotrimoxazole

Answer

Amoxicillin

Question 3

What is the drug of choice for Pneumocystis jirovecii pneumonia?

Accepted Answer

Cotrimoxazole

Answer

Doxycycline

Answer

Tetracycline

Answer

Dapsone

Question 4

The condition shown in the image is due to excessive/rapid usage of?

Accepted Answer

Vancomycin

Answer

Piperacillin

Answer

Metronidazole

Answer

Teicoplanin

Question 5

Which among the following fluoroquinolones has the longest half-life?

Accepted Answer

Moxifloxacin

Answer

Levofloxacin

Answer

Lomefloxacin

Answer

Ciprofloxacin

Question 6

What is the recommended daily dose of amphotericin B for a patient with suspected severe fungal infection?

Accepted Answer

120-160 mEq over 24 hours

Answer

40 mEq over 24 hours

Answer

60 mEq over 24 hours

Answer

80 mEq over 24 hours

Question 7

Which of the following is recommended as a dual-active drug targeting both HBV and HIV?

Accepted Answer

Tenofovir

Answer

Entecavir

Answer

Adefovir

Answer

Zidovudine

Question 8

Which of the following anti-influenza drugs can cause Livedo reticularis?

Accepted Answer

Amantadine

Answer

Laninamivir

Answer

Rimantidine

Answer

Zanamivir

Question 9

A healthcare worker has a needle-stick injury exposure to HIV. Which of the following drug regimens is indicated for post-exposure prophylaxis?

Accepted Answer

Zidovudine + Lamivudine + Indinavir for 4 weeks

Answer

Zidovudine + Lamivudine + Nevirapine for 4 weeks

Answer

Zidovudine + Stavudine for 4 weeks

Answer

Zidovudine + Lamivudine for 4 weeks

Question 10

Metronidazole is indicated in the treatment of which one of the following conditions?

Accepted Answer

Helicobacter pylori infection

Answer

Traveller's diarrhea

Answer

Escherichia coli-induced diarrhoea

Answer

Cryptosporidium-induced diarrhea

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?